The Indianapolis-based company received U.S. regulatory approval last week for its second medicine in 18 months in what it ...

Australians living with a range of debilitating conditions including juvenile arthritis, rare liver disease and multiple ...

"I am done with all of the sidetracks and the detours. I say we just run on through. Who fudging cares?" Even if it is the ...

Certain people risk severe or life-threatening reactions if they consume these products, according to an official alert.

Pain-sensing neurons in the gut kindle inflammatory immune responses that cause allergies and asthma, according to a new ...

Gland Pharma has received an approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) filed for Olopatadine Hydrochloride Ophthalmic ...

As they prepare for the J.P. Morgan Healthcare Conference next week, biotech leaders and analysts say companies are better ...

Indian shares were headed for a fourth straight session of declines on Thursday amid cautious sentiment, with U.S. tariff ...

In both trials, envudeucitinib showed greater skin clearance than placebo on both co-primary endpoints at week 16.

Pain sensing neurons in the gut kindle inflammatory immune responses that cause allergies and asthma, according to a new ...

FTX, the latest Fraxel upgrade, is non-ablative and uses the same dual-wavelength technology (1550–1927 nm) as its ...

Stocks like Tata Steel, NCL Industries, Infosys, Gland Pharma, Cipla, IRB Infrastructure Developers, Meesho, Adani Green ...